Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,728,738
+$4,804,500 QoQ
Shares Held
344,215
+6.0% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#93
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. EXEL ranks #47 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,728,738 | 344,215 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,924,238 | 324,650 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,489,102 | 330,575 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,415,765 | 349,050 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $16,248,020 | 368,603 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,937,927 | 377,517 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,012,807 | 390,775 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,510,269 | 405,020 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,402,890 | 462,968 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,752,169 | 537,386 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $13,993,007 | 583,285 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $11,601,410 | 530,957 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,240,074 | 535,849 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $10,099,081 | 520,303 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,017,266 | 686,862 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $10,721,200 | 683,750 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $14,146,877 | 679,485 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $17,979,939 | 793,116 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,862,271 | 484,807 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,011,895 | 568,207 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $9,126,561 | 500,909 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $16,667,173 | 737,812 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $13,073,838 | 651,412 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $17,354,903 | 709,812 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,883,128 | 669,045 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $10,962,854 | 636,635 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||